Cefepime/VNRX-5133 fixed-dose combination shows promise against resistant Gram-negative bacteria July 2, 2018
TAK-228 demonstrates potential for the treatment of NFE2L2-mutant squamous cell lung cancer July 2, 2018
Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news July 2, 2018
Phase Ib data on intravenous dexmedetomidine support BioXcel's development of sublingual BXCL-501 July 2, 2018
RSS